Cargando…

Benefit of Biennial Fecal Occult Blood Screening on Colorectal Cancer in England: A Population-Based Case-Control Study

BACKGROUND: The English national bowel cancer screening program offering a guaiac fecal occult blood test began in July 2006. In randomized controlled trials of guaiac fecal occult blood test screening, reductions in mortality were accompanied by reductions in advanced stage colorectal cancer (CRC)....

Descripción completa

Detalles Bibliográficos
Autores principales:	Castanon, Alejandra, Parmar, Dharmishta, Massat, Nathalie J, Sasieni, Peter, Duffy, Stephen W
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9468279/ https://www.ncbi.nlm.nih.gov/pubmed/35575409 http://dx.doi.org/10.1093/jnci/djac100

Ejemplares similares

A case–control study to evaluate the impact of the breast screening programme on breast cancer incidence in England
por: Blyuss, Oleg, et al.
Publicado: (2022)

A case-control study to evaluate the impact of the breast screening programme on mortality in England
por: Maroni, Roberta, et al.
Publicado: (2020)

An ongoing case-control study to evaluate the NHS breast screening programme
por: Massat, Nathalie J, et al.
Publicado: (2013)

An ongoing case–control study to evaluate the NHS Bowel Cancer Screening Programme
por: Massat, Nathalie J, et al.
Publicado: (2014)

Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening
por: Goede, S. Lucas, et al.
Publicado: (2017)

Screening for Colorectal Cancer by Immunochemical Fecal Occult Blood Testing
por: Saito, Hiroshi
Publicado: (1996)

Overdiagnosis in breast cancer screening: the importance of length of observation period and lead time
por: Duffy, Stephen W, et al.
Publicado: (2013)

By how much could screening by primary human papillomavirus testing reduce cervical cancer incidence in England?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Survival from Cervical Cancer Diagnosed Aged 20–29 Years by Age at First Invitation to Screening in England: Population-Based Study
por: Castanon, Alejandra, et al.
Publicado: (2020)

Is the recent increase in cervical cancer in women aged 20–24 years in England a cause for concern?
por: Castanon, Alejandra, et al.
Publicado: (2018)

Implementation of population screening for colorectal cancer by repeated fecal occult blood test in the Netherlands
por: Denters, Maaike J, et al.
Publicado: (2009)

Population-based colorectal cancer screening: comparison of two fecal occult blood test
por: Zubero, Miren B., et al.
Publicado: (2014)

Is It Necessary to Repeat Fecal Occult Blood Tests with Borderline Results for Colorectal Cancer Screening?
por: Lee, Eunyoung, et al.
Publicado: (2018)

Clinical impact of the immunochemical fecal occult blood test for colorectal cancer screening in Brazil
por: Teixeira, Cláudio R., et al.
Publicado: (2017)

Biology and Clinical Implications of Fecal Occult Blood Test Screen-Detected Colorectal Cancer
por: Mendis, Shehara, et al.
Publicado: (2022)

Optimization of screening strategies for colorectal cancer based on fecal DNA and occult blood testing
por: Yao, Tingting, et al.
Publicado: (2023)

Variation in cervical and breast cancer screening coverage in England: a cross-sectional analysis to characterise districts with atypical behaviour
por: Massat, Nathalie J, et al.
Publicado: (2015)

Colorectal cancer screening: Why immunochemical fecal occult blood tests may be the best option
por: Flitcroft, Kathy L, et al.
Publicado: (2012)

Colorectal cancer screening with fecal occult blood test: A 22-year cohort study
por: JIN, PENG, et al.
Publicado: (2013)

Barriers related to fecal occult blood test for colorectal cancer screening in moderate risk individuals
por: Javadzade, Seyed Homamodin, et al.
Publicado: (2014)

Stages of Adoption for Fecal Occult Blood Test and Colonoscopy Tests for Colorectal Cancer Screening in Korea
por: Bui, Nhung Cam, et al.
Publicado: (2018)

Multitarget stool DNA test compared with fecal occult blood test for colorectal cancer screening
por: Yang, Cuiping, et al.
Publicado: (2020)

Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population
por: Brenner, Hermann, et al.
Publicado: (2017)

Psychological distress and quality of life following positive fecal occult blood testing in colorectal cancer screening
por: Vermeer, Nina C. A., et al.
Publicado: (2020)

Advances in Fecal Occult Blood Tests: The FIT Revolution
por: Young, Graeme P., et al.
Publicado: (2014)

Predictors of adherence to repeat fecal occult blood test in a population-based colorectal cancer screening program
por: Pornet, C, et al.
Publicado: (2014)

Fecal Occult Blood Test Results of the National Colorectal Cancer Screening Program in South Korea (2006–2013)
por: Rim, John Hoon, et al.
Publicado: (2017)

Comment on “Fecal occult blood versus DNA testing: indirect comparison in a colorectal cancer screening population”
por: Ahlquist, David A
Publicado: (2017)

Effects of Fecal Occult Blood Immunoassay Screening for Colorectal Cancer—Experience from a Hospital in Central Taiwan
por: Yang, Pei-Yu, et al.
Publicado: (2023)

How many preterm births in England are due to excision of the cervical transformation zone? Nested case control study
por: Wuntakal, R., et al.
Publicado: (2015)

Benefits and harms of cervical screening from age 20 years compared with screening from age 25 years
por: Landy, R, et al.
Publicado: (2014)

Validity of Fecal Occult Blood Test in the National Cancer Screening Program, Korea
por: Shin, Aesun, et al.
Publicado: (2013)

Embedded Immunodetection System for Fecal Occult Blood
por: Lin, Kai-Wen, et al.
Publicado: (2021)

Modelled mortality benefits of multi-cancer early detection screening in England
por: Sasieni, Peter, et al.
Publicado: (2023)

An Evaluation of Mass Screening Using Fecal Occult Blood Test for Colorectal Cancer in Japan: A Case‐Control Study
por: Hiwatashi, Nobuo, et al.
Publicado: (1993)

Colonoscopy-related complications in a nationwide immunochemical fecal occult blood test-based colorectal cancer screening program
por: Mikkelsen, Ellen M, et al.
Publicado: (2018)

Is a delay in the introduction of human papillomavirus-based cervical screening affordable?
por: Castañon, Alejandra, et al.
Publicado: (2018)

Prediction of cervical cancer incidence in England, UK, up to 2040, under four scenarios: a modelling study
por: Castanon, Alejandra, et al.
Publicado: (2017)

Is cervical screening preventing adenocarcinoma and adenosquamous carcinoma of the cervix?
por: Castanon, Alejandra, et al.
Publicado: (2016)

Effectiveness of cervical screening with age: population based case-control study of prospectively recorded data
por: Sasieni, Peter, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_3hebjburu6vqkljvb9v6q23t52